American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$276M |
| 2 |
NVIDIA
NVDA
|
+$243M |
| 3 |
Meta Platforms (Facebook)
META
|
+$206M |
| 4 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$165M |
| 5 |
Colgate-Palmolive
CL
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Microsoft
MSFT
|
+$544M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$322M |
| 4 |
L3Harris
LHX
|
+$254M |
| 5 |
Idexx Laboratories
IDXX
|
+$227M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.01% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.99% |
| 4 | Consumer Discretionary | 11.07% |
| 5 | Industrials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOUS
2501
DELISTED
Anywhere Real Estate
HOUS
| $80.2K | ﹤0.01% |
19,379
+9,363
| +93% | +$63.8K |
|
2502
iHeartMedia
IHRT
$469M
| $79.2K | ﹤0.01% |
21,283
+7,689
| +57% | +$49K |
|
2503
Archer Aviation
ACHR
$5.16B
| $77K | ﹤0.01% |
27,996
+6,313
| +29% | +$17K |
|
|
SGMO
2504
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $75.7K | ﹤0.01% |
44,546
+4,307
| +11% | +$12.3K |
|
|
FSR
2505
DELISTED
Fisker Inc.
FSR
| $75.5K | ﹤0.01% |
+12,630
| New | +$87K |
|
2506
Kodak
KODK
$983M
| $72.4K | ﹤0.01% |
17,486
+2,589
| +17% | +$9.35K |
|
|
TTSH
2507
DELISTED
Tile Shop Holdings
TTSH
| $71.3K | ﹤0.01% |
15,603
+1,734
| +13% | +$8.71K |
|
2508
Ardelyx
ARDX
$1B
| $71K | ﹤0.01% |
+15,475
| New | +$52.2K |
|
|
PTRA
2509
DELISTED
Proterra Inc. Common Stock
PTRA
| $69.5K | ﹤0.01% |
46,053
+10,102
| +28% | +$38K |
|
|
OPTU
2510
Optimum Communications Inc
OPTU
$230M
| $69.3K | ﹤0.01% |
21,944
-79,874
| -78% | -$340K |
|
2511
Sutro Biopharma
STRO
$355M
| $65.7K | ﹤0.01% |
1,466
+184
| +14% | +$11.7K |
|
2512
Ardagh Metal Packaging
AMBP
$3.14B
| $64.5K | ﹤0.01% |
16,085
+390
| +2% | +$1.92K |
|
|
DNMR
2513
DELISTED
Danimer Scientific, Inc.
DNMR
| $63.9K | ﹤0.01% |
518
+87
| +20% | +$7.96K |
|
2514
Atara Biotherapeutics
ATRA
$75.7M
| $63.3K | ﹤0.01% |
905
+302
| +50% | +$29.3K |
|
2515
Atea Pharmaceuticals
AVIR
$414M
| $62.2K | ﹤0.01% |
19,034
+1,671
| +10% | +$6.78K |
|
2516
Butterfly Network
BFLY
$2.47B
| $61.5K | ﹤0.01% |
37,525
+6,948
| +23% | +$16.2K |
|
|
CO
2517
DELISTED
Global Cord Blood Corporation
CO
| $61.5K | ﹤0.01% |
20,591
| – | – |
|
|
NIU
2518
Niu Technologies
NIU
$166M
| $61.1K | ﹤0.01% |
15,226
+3
| +0% | +$14 |
|
2519
Adicet Bio
ACET
$77.6M
| $59.7K | ﹤0.01% |
+639
| New | +$80.2K |
|
|
MTTR
2520
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $58.1K | ﹤0.01% |
22,164
+1,098
| +5% | +$3.35K |
|
|
QVCGA
2521
DELISTED
QVC Group Inc Series A
QVCGA
| $57.4K | ﹤0.01% |
1,303
+405
| +45% | +$36.4K |
|
2522
Sana Biotechnology
SANA
$1.11B
| $57.4K | ﹤0.01% |
18,465
+7,734
| +72% | +$30.9K |
|
2523
Fulcrum Therapeutics
FULC
$282M
| $57.2K | ﹤0.01% |
+20,203
| New | +$181K |
|
|
TUYA
2524
Tuya Inc
TUYA
$1.08B
| $55.7K | ﹤0.01% |
29,178
+12,155
| +71% | +$27.4K |
|
2525
AvePoint
AVPT
$2.77B
| $55.1K | ﹤0.01% |
+13,925
| New | +$62.8K |
|
Similar funds
American Century Companies's Q1 2023 Portfolio in Review
As of Q1 2023, American Century Companies held 2,730 positions worth $127B, up 3.7% from $122B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
American Century Companies's Q1 2023 filing shows 153 new, 1,696 increased, 700 reduced and 63 closed positions. Its largest new stake was Atlassian: 260,346 shares worth $44.6M. The largest sale was Amazon, an estimated $615M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q1 2023 buy was Atlassian: 260,346 shares worth $44.6M.
- American Century Companies added most to Humana in Q1 2023, an estimated $276M increase.
- American Century Companies's biggest Q1 2023 reduction was Amazon, cutting an estimated $615M.
- American Century Companies fully exited SVB Financial Group in Q1 2023, selling an estimated $73M.
- American Century Companies's ten largest holdings make up 20% of its $127B portfolio in Q1 2023.
- American Century Companies opened 153 new positions and closed 63 in Q1 2023.
- American Century Companies's portfolio value rose 3.7% quarter-over-quarter to $127B.
Based on American Century Companies's 13F filing for Q1 2023, filed 11 May 2023.